8-bromo cyclic adenosine monophosphate

Preferred Label : 8-bromo cyclic adenosine monophosphate;

MeSH definition : A long-acting derivative of cyclic AMP. It is an activator of cyclic AMP-dependent protein kinase, but resistant to degradation by cyclic AMP phosphodiesterase.;

MeSH synonym : amp, br cycl; br cycl amp; cyclic amp, 8-br; cyclic amp, 8-bromo; 8 br cyclic amp; 8 bromo camp; 8 bromoadenosine 3',5' cyclic monophosphate; 8-bromo cyclic amp; 8-bromoadenosine 3',5'-cyclic monophosphate; 8-bromo-camp; 8-br cyclic amp; 8 bromo cyclic amp; 8 bromo cyclic adenosine monophosphate;

CISMeF synonym : 8-bromoadenosine cyclic 3',5'-(hydrogen phosphate);

MeSH hyponym : 8-Bromo cyclic adenosine monophosphate, monosodium salt; 8-Bromo cyclic adenosine monophosphate, sodium salt; 8 Bromo Cyclic Adenosine Monophosphate, Sodium Salt; 8 Bromo Cyclic Adenosine Monophosphate, Monosodium Salt;

MeSH CAS label : adenosine, 8-bromo-, cyclic 3',5'-(hydrogen phosphate);

MeSH Related Number : 8-Bromo cyclic adenosine monophosphate, sodium salt; 8-Bromo cyclic adenosine monophosphate, monosodium salt; 70475-83-1 (Na salt); 76939-46-3 (mono-Na salt);

Registry Number MeSH : 23583-48-4;

Related CAS MeSH : 70475-83-1 (8-Bromo cyclic adenosine monophosphate, sodium salt); 76939-46-3 (8-Bromo cyclic adenosine monophosphate, monosodium salt);

MeSH annotation : DF: BR CAMP;

Codes EINECS : 245-760-6;

Is substance : O;

Details

Origin ID

D015124;

UMLS CUI

C0000661;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- 8-bromoadenosine cyclic 3',5'-(hydrogen phosphate) [Substance BNPC]
Record concept(s)
- 8-Bromo cyclic adenosine monophosphate [MeSH concept]
- 8-Bromo cyclic adenosine monophosphate, monosodium salt [MeSH concept]
- 8-Bromo cyclic adenosine monophosphate, sodium salt [MeSH concept]
Related MeSH Supplementary Concept(s)
- 8-bromoadenosine-3',5'-cyclic monophosphorothioate [MeSH Supplementary Concept]
- 8-chloro-cyclic adenosine monophosphate [MeSH Supplementary Concept]
Semantic type(s)
- Nucleic Acid, Nucleoside, or Nucleotide [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- 8-bromoadenosine cyclic 3',5'-(hydrogen phosphate) [Substance BNPC]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients